Font J, Vidal J, Cervera R, López-Soto A, Miret C, Jiménez de Anta M T, Ingelmo M
Department of Internal Medicine, Hospital Clínic, Barcelona, Catalonia, Spain.
Lupus. 1995 Feb;4(1):47-9. doi: 10.1177/096120339500400110.
The objective of this work was to determine whether HIV-1 and HIV-2 could be involved in the pathogenesis of systemic lupus erythematosus (SLE). Seventy-five consecutive Caucasian patients with SLE presenting at one institution over a 2-year period were studied. Serum samples were surveyed for anti-HIV-1 antibodies by a commercial ELISA coated with HIV-1-p24. For confirmation, conventional immunoblots were performed with the following antigens: HIV-1-gp41, p31, p24 and p17 (recombinant) and HIV-2-gp36 (synthetic peptide). Additionally, Western blots with HIV-1-gp160, gp120, gp41, p65, p51, p24 and p18 bands were applied. Seventeen (23%) patients exhibited reactivity with HIV-1-p24 in the ELISA, but in the immunoblots and Western blots these sera samples were negative. Patients with SLE may exhibit a reactivity with HIV-1-p24 in the ELISA for HIV infection screening but not in the confirmatory blots. This false-positive reactivity is probably due to molecular mimicry between autoantigens and retroviruses or a contaminant or artefacts in the antigen preparation procedure.
这项工作的目的是确定HIV-1和HIV-2是否可能参与系统性红斑狼疮(SLE)的发病机制。对在两年期间于一家机构就诊的75例连续的白种人SLE患者进行了研究。通过用HIV-1-p24包被的商业ELISA检测血清样本中的抗HIV-1抗体。为了进行确认,使用以下抗原进行传统免疫印迹:HIV-1-gp41、p31、p24和p17(重组体)以及HIV-2-gp36(合成肽)。此外,还应用了具有HIV-1-gp160、gp120、gp41、p65、p51、p24和p18条带的蛋白质印迹法。17例(23%)患者在ELISA中对HIV-1-p24呈反应性,但在免疫印迹和蛋白质印迹中这些血清样本为阴性。SLE患者在用于HIV感染筛查的ELISA中可能对HIV-1-p24呈反应性,但在确认性印迹中则不然。这种假阳性反应性可能是由于自身抗原与逆转录病毒之间的分子模拟,或者是抗原制备过程中的污染物或假象。